Starting January 1, 2026, these medications will no longer be covered for weight loss or weight loss-related indications: Ozempic Rybelsus Mounjaro Victoza Byeta Bydureon Trulicity Ensuring Continuation of Therapy If you are currently prescribed any GLP-1 medication for an approved indication, it is important to ensure your prescriber includes the appropriate diagnosis code (ICD-10) when submitting your prescription
Adequate protein intake commonly cited in weight-loss research at roughly 1.2-1.6 g per kg of body weight per day, higher for older or very active individuals is the strongest dietary signal to retain muscle in a deficit
Refer to our guide on how long semaglutide takes to work for realistic timeline expectations
Regular soda and 50 of you are doing diet soda and you don't get to choose, then what we can assume is that any difference in baseline characteristics amongst the participants will be randomly distributed over the treatment groups
Ethical approval All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Shonan Health Innovation Park, iPark Institute Co., Ltd., accredited by AAALAC International, and conducted in accordance with institutional guidelines